Sort   by:  
 Page size 
UnknownCoexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma.
Not available
S-EPMC3260832 | biostudies-literature
UnknownDual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer.
Not available
S-EPMC4607622 | biostudies-literature
Unknownc-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell death.
Not available
S-EPMC3320136 | biostudies-literature
UnknownGenome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
Not available
S-EPMC3070566 | biostudies-literature
UnknownSynthesis, anti-leishmanial and molecular docking study of bis-indole derivatives.
Not available
S-EPMC6685257 | biostudies-literature
UnknownPolymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Not available
S-EPMC2492854 | biostudies-literature
UnknownBortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.
Not available
S-EPMC3081207 | biostudies-literature
UnknownA very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.
Not available
S-EPMC4109832 | biostudies-literature
UnknownPrognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations.
Not available
S-EPMC2922191 | biostudies-literature
UnknownOverexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.
Not available
S-EPMC3146599 | biostudies-literature
Sort   by:  
 Page size